Heparin Sodium and Sodium Chloride
- Manufacturer
- Baxter Healthcare Corporation | Baxter Healthcare Ltd
- Effective date
- 2020-07-27
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 4
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 23:20:14
Label at a glance#
Label contents#
Full prescribing information#
PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

Code B0953G
500 ml
Baxter Logo
Heparin Sodium BP 2000 IU/L in
0.9% w/v Sodium Chloride IV Infusion
VIAFLEX container
Sterile nonpyrogenic
Solution for Infusion
Single Dose
Each 500 ml contains
Heparin Sodium (Mucous) 1000 IU
Sodium Chloride 4.5 g
Disodium Phosphate 12H 2 0 2.9 g
Citric Acid (Monohydrate) 0.202g
Water for Injections
mmol per 500 ml (approx)
Sodium 93
Chloride 77
Phosphate 8
Citrate 1
For intravenous administration
Store out of reach and sight of children
Do not remove from overwrap until ready for use
Do not use unless solution is clear and container is
undamaged
Do not add any supplementary medication
For use under medical supervision
Do not store above 25°C
Discard any unused portion
Do not reconnect partially used bags
Baxter Healthcare Ltd
Thetford Norfolk IP24 3SE
PL00116/0130
POM symbol
Heparin Sodium BP 2000 IU/L in
0.9% w/v Sodium Chloride
IV Infusion
TH-35-01-749
Lot
Expiry
1
2
3
4

Code B0944
1000 ml
Baxter Logo
Heparin Sodium BP 2000 IU/L in
0.9% w/v Sodium Chloride IV Infusion
VIAFLEX container
Sterile nonpyrogenic
Solution for Infusion
Single Dose
- Each 1000 ml contains
Heparin Sodium (Mucous) 2000 IU
Sodium Chloride 9 g
Disodium Phosphate 12H 2 0 5.8 g
Citric Acid (Monohydrate) 0.405 g
Water for Injections
mmol per 1000 ml (approx)
Sodium 186
Chloride 154
Phosphate 16
Citrate 2
For intravenous administration
Store out of reach and sight of children
Do not remove from overwrap until ready for
use
Do not use unless solution is clear and container
is undamaged
Do not add any supplementary medication
For use under medical supervision
Do not store above 25°C
Discard any unused portion
Do not reconnect partially used bags
Baxter Healthcare Ltd
Thetford Norfolk IP24 3SE
PL00116/0130
POM symbol
TH-35-01-237
Heparin Sodium BP 2000 IU/L in
0.9% w/v Sodium Chloride
IV Infusion
Lot
Expiry
1
2
3
4
5
6
7
8
9
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0338-9556-20 | ML - Milliliter | 0338-9556 | def12cc4-1ca2-4ba8-8967-627e2f31439a | 1 | 2018-01-12 |
| 0338-9552-10 | ML - Milliliter | 0338-9552 | 853bf164-909e-4858-9c6d-3bb0f9dad097 | 1 | 2018-02-20 |
Products#
Every source-derived product name is available through these pages.
- Heparin Sodium and Sodium Chloride
- heparin sodium
- HEPARIN
- SODIUM CHLORIDE
- SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
- CITRIC ACID MONOHYDRATE
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0338-9556 | 0338-9556-20 |
| 0338-9552 | 0338-9552-10 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| HEPARIN SODIUM | ZZ45AB24CA | ACTIM |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | IACT |
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
| WATER | 059QF0KO0R | IACT |
| HEPARIN SODIUM | ZZ45AB24CA | ACTIM |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 22ADO53M6F | IACT |
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
| WATER | 059QF0KO0R | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 02bfe934-cfd5-4fa5-be8d-54a475f0541e | cf6ce51b-dc0c-424e-9fac-e4713bd095ed | 2020-07-27 | 02bfe934-cfd5-4fa5-be8d-54a475f0541e cf6ce51b-dc0c-424e-9fac-e4713bd095ed |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.













